18 reports

  • United Kingdom Atopic Dermatitis Market

It is most common dermatologic condition in infants but can also show symptoms in older children and adults.

  • Dermatological Condition
  • World
  • Aclaris Therapeutics, Inc.
  • Allergan plc
  • Dermira, Inc.
  • MAR 04, 2019: BIOPHARMX COMPLETES ENROLLMENT IN PHASE 2B TRIAL OF BPX-04 FOR PATIENTS WITH PAPULOPUSTULAR ROSACEA
  • JUL 08, 2019: SOL-GEL ANNOUNCES POSITIVE TOP-LINE RESULTS FROM EPSOLAY PHASE 3 PROGRAM IN PAPULOPUSTULAR ROSACEA

Rosacea is a chronic dermatologic condition characterized by redness, stinging and inflammatory lesions primarily on the face.

  • Dermatological Condition
  • Therapy
  • United States
  • Product Initiative
  • Foamix Ltd.
  • FEATURED NEWS & PRESS RELEASES

Rosacea is a chronic dermatologic condition characterized by redness, stinging and inflammatory lesions primarily on the face.

  • Dermatological Condition
  • United States
  • Company
  • Product Initiative
  • Foamix Ltd.
  • FEATURED NEWS & PRESS RELEASES

Oct ##, 2019: Bausch Health' s Ortho Dermatologics business to present data on acne drug tretinoin at The Fall Clinical Dermatology Conference Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, one of the largest prescript

  • Dermatological Condition
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Atopic Dermatitis Market: Revenue in USD million, India, 2016-2024
  • 5.4.3 ASIA-PACIFIC

According to a 2015 research article published by Sanjeev Handa et. at., in Indian Journal of Dermatology, atopic dermatitis (AD) is a common dermatologic condition with a prevalence rate varying between ##. ##% and ##%, and it has been rising over time.

  • Dermatological Condition
  • North America
  • United States
  • World
  • Nestlé S.A.
  • 2.6 Epidemiology

Clinics in Dermatology; ##(##): ##-## Tran T-A (2017).

  • Dermatological Condition
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.

The condition usually begins during early infancy and childhood, but can persist into, or start during, adulthood.

  • Dermatological Condition
  • Japan
  • United States
  • World
  • Forecast
  • LICENSING AGREEMENTS

Alopecia areata is an autoimmune dermatologic condition, typically characterized by patchy, non-scarring hair loss on the scalp and body.

  • Dermatological Condition
  • Therapy
  • United States
  • Company
  • Aclaris Therapeutics, Inc.

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

  • Dermatological Condition
  • Pathology
  • Therapy
  • World
  • Product Initiative
  • 1.1.1. FAST FACTS - GLOBAL DERMATOLOGICAL DRUGS MARKET
  • 2.1 CURRENT TRENDS, CHALLENGES AND DEVELOPMENTS

GMR DATA - FOR WHICH CONDITION IS THE DERMATOLOGICAL TREATMENT MARKET SHRINKING?

  • Dermatological Condition
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • 4.1 ETIOLOGY AND PATHOPHYSIOLOGY

Dermatology; ##(##): ##-##.

  • Dermatological Condition
  • Foamix Ltd.
  • Galderma S.A.
  • Novan, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • 2.6.3 Psoriasis

Approximately one-third of the US population suffers from at least one active skin condition (Johnson, 2004).

  • Dermatological Condition
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.
  • Clinical and Commercial Landscape

Dermatology; ## (##).

  • Dermatological Condition
  • Healthcare
  • Pathology
  • Therapy
  • Deals & Alliance
  • Clinical and Commercial Landscape
  • 4.4.3 Psoriasis

Approximately one third of the US population suffers from at least one active dermatological condition (Johnson, 2004).

  • Dermatological Condition
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.
  • Pfizer Inc.
  • Latest Clinical Trials News on Epidermolysis Bullosa

EBS is the most common form of epidermolysis bullosa, a rare dermatologic condition where patients (many of them children) have a genetic defect that compromises the structural integrity of their skin, making it particularly fragile and prone to blistering over their entire bodies.

  • Cell Therapy
  • Dermatological Condition
  • World
  • Product Initiative
  • Amryt Pharma plc
  • AMG-0101 - DRUG PROFILE

There was no statistically significant difference between the NF-kappaB Decoy Oligonucleotide treated group and the placebo group in the primary end point of the improvement in the dermatological condition scores at week ##.

  • Dermatological Condition
  • Japan
  • World
  • Company Operations
  • Shionogi & Co., Ltd.

Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition.

  • Dermatological Condition
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • Merck & Co., Inc.
  • Product Development Milestones

Approximately one-third of the US population suffers from at least one active skin condition.

  • Autoimmune Disease
  • Dermatological Condition
  • Pharmaceutical
  • Company
  • Product Initiative